Dyskinesia are a category of movement disorders characterized by involuntary muscle movements. They can be medication-induced, chronic, or non-motor in nature. Here is the latest research.

January 23, 2021

Secundilactobacillus folii sp. nov., isolated from fermented tea leaves in Thailand.

International Journal of Systematic and Evolutionary Microbiology
Sukanya PhuengjayaemSomboon Tanasupawat
January 16, 2021

Ambulatory surface electromyography with accelerometry for evaluating daily motor fluctuations in Parkinson's disease.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Saara M RissanenEero Pekkonen
January 15, 2021
Open Access

Spectrum of esophageal motility disorders in patients with liver cirrhosis

World Journal of Hepatology
Mohamed KhalafPuja Sukhwani Elias
January 16, 2021
Open Access

Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia

ERJ Open Research
Alex Gileles-HillelOded Breuer
January 15, 2021
Open Access

Cognitive impairment and levodopa induced dyskinesia in Parkinson's disease: a longitudinal study from the PACOS cohort

Scientific Reports
Antonina LucaAlessandra Nicoletti
January 12, 2021

Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications

Movement Disorders Clinical Practice
Jared T HinkleGregory M Pontone
January 22, 2021

Etiology, localization of the lesion, and prognosis for patients firstly diagnosed in ophthalmology department with oculomotor nerve palsy.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Xin Zhang, Shihui Wei
January 14, 2021

Evaluation of esophageal motor function in patients with gastroesophageal reflux using multiple rapid swallows

Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
Mayank Jain, Vinodini Agrawal
January 23, 2021

Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia.

The European Respiratory Journal
Amelia ShoemarkJane S Lucas
January 16, 2021

Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study

Journal of Neurosurgery
Shiro HorisawaTakaomi Taira
January 23, 2021

MR-guided focused ultrasound pallidotomy for Parkinson's disease: safety and feasibility.

Journal of Neurosurgery
Howard EisenbergPaul S Fishman
January 20, 2021

Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden

Journal of Geriatric Psychiatry and Neurology
Alessandro Reffo, Carlo Gabelli
January 22, 2021

Deep brain stimulation for Parkinson's disease in Pakistan: Current status, opportunities and challenges.

JPMA. the Journal of the Pakistan Medical Association
Nabeel Muzaffar SyedDanish Ejaz Bhatti
January 12, 2021
Case Report

Late-Onset Tay-Sachs Disease in an Irish Family

Movement Disorders Clinical Practice
Stela LefterAisling M Ryan
January 16, 2021

Motor dysfunction in mild cognitive impairment as tested by kinematic analysis and transcranial magnetic stimulation.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Donato ColellaMatteo Bologna

Sign up to follow this feed and discover related papers.

Related Feeds


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alpha-Synuclein Structure & Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-synuclein structure and function.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.


Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Cervical Dystonia

Cervical dystonia, or spasmodic torticollis, is a neurological disorder in which involuntary muscle contractions in the neck cause abnormal head and neck movements. Current treatment options include botulinum toxin injections, oral medications, and surgery. Find the latest research on cervical dystonia here.

© 2021 Meta ULC. All rights reserved